California Added FTD to Disease Registry
Governor Gavin Newsom signed legislation requiring healthcare providers to report frontotemporal degeneration diagnoses.
Updated on Oct. 1, 2026 in Alzheimer’s
Live Poll
Should states mandate the registry of specific disease diagnoses to improve research and patient care?
Governor Gavin Newsom has signed Senate Bill 1047, which officially adds frontotemporal degeneration to the state's Neurodegenerative Disease Registry. The new law requires healthcare providers to report every diagnosis of the condition to the California Department of Public Health.
Why it matters
The mandate addresses critical reporting gaps that currently hinder researchers, clinicians, and policymakers from understanding the impact of the disease and allocating necessary state resources.
Frontotemporal degeneration is classified as the most frequent form of dementia for individuals under age 60. The state registry now tracks this condition alongside Alzheimer's, Parkinson's, multiple sclerosis, and amyotrophic lateral sclerosis.
The players
Gavin Newsom
He is the Governor of California who officially signed the legislation into law.
California Department of Public Health
This state agency will now receive mandatory reports from healthcare providers regarding frontotemporal degeneration diagnoses.
Senator Niello
He is a state senator who met with advocates in Sacramento to discuss the disease registry legislation.
The details
The bill mandates that all healthcare providers report frontotemporal degeneration diagnoses to the California Department of Public Health. This legislative move seeks to improve tracking, following the precedent set by New York as the first state to establish such a registry.
Timeline
August 3, 2026: Advocates met with Senator Niello in Sacramento.
September 30, 2026: Governor Gavin Newsom signed SB 1047 into law.
The Big Picture
California's new law follows the precedent set by New York's first frontotemporal degeneration registry. By standardizing reporting across the state, California aligns its surveillance efforts with existing models for tracking neurodegenerative conditions.
This legislation streamlines data collection, which may eventually lead to better-informed care paths and resource allocation for patients across the state. While it does not change individual treatment protocols, it facilitates a more comprehensive understanding of the condition's local prevalence.
The takeaway
The unanimous passage of this bill highlights the growing urgency to address early-onset dementia through robust state-level data collection. Residents and families affected by the disease may benefit from the improved research infrastructure and resource planning supported by this registry expansion.
Further reading
For more on how state policies affect those with memory-related conditions, see our coverage on Alzheimer’s.
Live Poll
Should states mandate the registry of specific disease diagnoses to improve research and patient care?
